March 27, 2023, Vancouver, British Columbia: Gemina Laboratories Ltd. (CSE: GLAB) (FRA:8I7) (the “Company” or “Gemina”) is pleased to announce that it will host a live investor webinar presentation on Thursday, March 30, 2023, at 2:00 PM ET. During the webcast, Brian Firth, CEO, will conduct a presentation that will cover key areas of Gemina’s business. After the formal presentation, participants will have the opportunity to ask questions through an interactive Q&A portal. To listen to the webcast or to ask questions during the live event, please pre-register by clicking on the following link:
Registration Link: Gemina Webinar Registration
An archived version of the webcast and presentation will be available on the Company’s website following the live event: www.geminalabs.com/investors.
On Behalf of the Board of Directors,
John Davies, Chairman Gemina Laboratories Ltd.
About Gemina Laboratories Ltd.
Gemina Labs is a biosensor and diagnostic company with a transformative, patented, proprietary chemistry technology platform that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. Our technologies drive testing platforms that are fast, affordable, accurate, and easily self-administered. Our own product pipeline includes platforms for the rapid testing of COVID-19, influenza, tuberculosis and other viruses. Additional information on the Company can be found at www.geminalabs.com.
Latest Posts
Anodyne Chemistries Secures Trademark for “Anozyme”
Read More
Syniad’s Brokkr Appoints Richard Shaw to its Advisory Board
Read More Syniad’s Brokkr Appoints Samantha Espley to its Advisory Board
Read More